Table 2.
Characteristics of audit patients.
| Patient characteristics | n (%) |
|---|---|
| Total patients | 8,937 |
| Female | 7,941 (88.9) |
| Male | 996 (11.1) |
| Age group (years) | |
| 20–29 | 26 (0.3) |
| 30–39 | 163 (1.8) |
| 40–49 | 732 (8.2) |
| 50–59 | 1,969 (22.0) |
| 60–69 | 2,534 (28.4) |
| 70–79 | 2,545 (28.5) |
| >80 | 968 (10.8) |
| Autoantibodies | |
| AMA | 7,518 (84.1) |
| PBC-specific ANA | 1,459 (16.3) |
| PBC/AIH-overlap | 679 (7.6) |
| Clinic | |
| Hepatology | 7,263 (81.3) |
| General gastroenterology | 1,674 (18.7) |
| Nation | |
| England | 7,690 (86.0) |
| Northern Ireland | 57 (0.6) |
| Scotland | 953 (10.7) |
| Wales | 237 (2.7) |
AIH, autoimmune hepatitis; AMA, anti-mitochondrial autoantibody; ANA, anti-nuclear autoantibody; PBC, primary biliary cholangitis.